Observational Study of Pertuzumab Safety in Participants With Breast Cancer
Clinical trial NCT02266173 · COMPLETED
Trial details
- NCT number
- NCT02266173
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-02-05
- Primary completion
- 2021-03-08
- Enrollment
- 1130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.